Search
InsiderInsights.com

Hawkins Richard J (1307632)

Hawkins Richard J has been a registered insider at 3 firms since 2004. As Chief Executive Officer at NEWLINK GENETICS CORP, Hawkins Richard J last made a transaction on 9/23/2022. As a Director at ADVENTRX Pharmaceuticals Inc, Hawkins Richard J last made a transaction on 12/7/2022. As a Director at SciClone Pharmaceuticals, Inc., Hawkins Richard J last made a transaction on 8/12/2016.

NEWLINK GENETICS CORP (NLNK, LUMO)

Titles: CEO,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
2 0% -63% -63% 1 6 Month 2 0% -- -- --
2 0% -59% -59% 1 3 Month 2 0% -- -- --
2 100% 1% 1% 2 1 Month 2 0% -- -- --
2 50% -0% -0% 3 1 Week 2 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/14/2023 12:06 AM EST Latest Transaction Date: 9/23/2022
Average days between Transaction and Entered Dates: 1

Mast Therapeutics, Inc. (ANX, MSTX, SVRA)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 100% 35% -- -- 1 Year 1 0% -- -- --
1 100% 32% -- -- 9 Month 1 0% -- -- --
2 100% 53% 53% 60 6 Month 2 0% -- -- --
2 50% 27% 27% 59 3 Month 2 0% -- -- --
2 100% 13% 13% 9 1 Month 2 0% -- -- --
2 50% 4% 4% 11 1 Week 2 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 100% -80% -- -- 1 Year 1 0% -- -- --
1 100% -78% -- -- 9 Month 1 0% -- -- --
1 100% -94% -- -- 6 Month 1 0% -- -- --
1 100% -81% -- -- 3 Month 1 0% -- -- --
1 100% -79% -- -- 1 Month 1 0% -- -- --
1 100% -4% -- -- 1 Week 1 0% -- -- --
Scorecards Updated 6/14/2023 12:06 AM EST Latest Transaction Date: 12/7/2022
Average days between Transaction and Entered Dates: 1

SCICLONE PHARMACEUTICALS INC (SCLN)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
2 0% -13% -13% 25 1 Year 2 0% -- -- --
2 50% 19% 19% 89 9 Month 2 0% -- -- --
2 50% 1% 1% 67 6 Month 2 0% -- -- --
2 50% 3% 3% 48 3 Month 2 0% -- -- --
2 100% 8% 8% 6 1 Month 2 0% -- -- --
2 50% -2% -2% 7 1 Week 2 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
7 0% 30% 38% 47 1 Year 7 0% -- -- --
7 43% -2% 0% 16 9 Month 7 0% -- -- --
7 71% -2% -4% 14 6 Month 7 0% -- -- --
7 86% -12% -15% 25 3 Month 7 0% -- -- --
7 71% 3% -1% 31 1 Month 7 0% -- -- --
7 86% -1% -1% 9 1 Week 7 0% -- -- --
Scorecards Updated 6/14/2023 12:06 AM EST Latest Transaction Date: 8/12/2016
Average days between Transaction and Entered Dates: 3
© 2024 InsiderInsights.com